Thomas Hospital
750 Morphy Avenue, Fairhope, AL, 36532 · (251) 928-2375
$268.8M
Net patient revenue, FY 2025
$268.8M
Net patient revenue, FY 2025
Beds
169
FY 2025
Star rating
2 of 5
Patient survey: 3 of 5
Net patient revenue
$268.8M
FY 2025
Net income
$19.1M
Patient care margin 4.9%
Discharges
11,198
Occupancy 88.1%
Clinicians
597
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
5 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $268.8M | $255.8M | 4.9% | $19.1M | 11,198 | $6.0M | 26.5% | 8.1% |
| 2024 | $255.6M | $245.0M | 4.1% | $15.5M | 11,283 | $8.2M | 26.1% | 7.8% |
| 2023 | $244.7M | $229.4M | 6.2% | $22.9M | 11,925 | $2.3M | 26.8% | 9.8% |
| 2022 | $184.9M | $220.0M | -19.0% | -$39.2M | 10,712 | $12.1M | 29.5% | 13.3% |
| 2021 | $184.9M | $185.6M | -0.4% | -$4.9M | 10,337 | $14.2M | 27.2% | 10.6% |
| 2020 | $184.9M | $173.3M | 6.3% | $7.4M | 10,337 | $9.2M | 32.1% | 15.1% |
Quality of care
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
Death rates
| Death rate after heart bypass surgery | 3.3% | US median 2.3% |
| Death rate for COPD patients | 11.2% | US median 8.5% |
| Death rate for heart attack patients | 11.3% | US median 11.8% |
| Death rate for heart failure patients | 11.4% | US median 11% |
| Hospital-wide death rate within 30 days | 3.7% | US median 3.9% |
| Death rate for pneumonia patients | 20.1% | US median 15.2% |
| Death rate for stroke patients | 14.2% | US median 11.6% |
Readmissions
| Readmission rate after heart bypass surgery | 11.3% | US median 10.9% |
| Readmission rate for COPD | 19.2% | US median 19.8% |
| Readmission rate after a heart attack | 13.7% | US median 14.4% |
| Readmission rate for heart failure | 21.9% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.9% | US median 5.8% |
| Readmission rate for pneumonia | 17.6% | US median 17.2% |
Patient safety
| Complications after hip or knee replacement | 5.8% | US median 4.1% |
| Serious complications (patient safety composite) | 1.10 | US median 0.96 |
Infections
| C. diff intestinal infections (ratio to expected) | 0.94 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.67 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.72 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.50 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 1.07 | US median 0.40 |
Patient survey
| Doctors always communicated well | 78% | US median 79% |
| Nurses always communicated well | 80% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 61% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 69% | US median 72% |
| Room and bathroom always clean | 63% | US median 73% |
| Patients who would definitely recommend the hospital | 72% | US median 71% |
Timely and effective care
| Patients who left the emergency department before being seen | 5% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 188 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 79% | US median 65% |
| Healthcare workers given the flu vaccine | 49% | US median 79% |
Hospital profile
- Medicare certification number (CCN)
- 010100
- Organization NPI
- 1447303227
- Legal name
- Gulf Health Hospitals Inc
- County
- Baldwin County, AL
- Ownership
- Government (local)
- Teaching
- Graduate teaching
- In Medicare since
- 1966
- Full-time employees
- 1,089
- Health system
- Infirmary Health System
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other Infirmary Health System hospitals
| Hospital | Place |
|---|---|
| Mobile Infirmary Medical Center | Mobile, AL |
| Infirmary LTAC Hospital | Mobile, AL |
| North Baldwin Infirmary | Bay Minette, AL |
| Atmore Community Hospital | Atmore, AL |
Similar short-term acute care hospitals in Alabama
Closest in number of beds
| Hospital | Place | Beds |
|---|---|---|
| Springhill Medical Center | Mobile, AL | 170 |
| Medical West, An Affiliate of UAB Health System | Bessemer, AL | 168 |
| Cullman Regional Medical Center | Cullman, AL | 162 |
| Helen Keller Hospital | Sheffield, AL | 178 |
| Crestwood Medical Center | Huntsville, AL | 157 |
| Flowers Hospital | Dothan, AL | 183 |
Medicare hospital stays
Inpatient stays by diagnosis related group (DRG), 2024
| Diagnosis group | Stays | Average charge | Medicare pays per stay | All hospitals |
|---|---|---|---|---|
| DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | 194 | $45,270.80 | $12,659.72 | $15,524.21 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 117 | $28,950.48 | $8,392.81 | $10,022.34 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 80 | $22,265.49 | $4,582.00 | $5,662.18 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 71 | $20,339.92 | $4,847.56 | $5,985.69 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 59 | $34,080.54 | $10,180.78 | $12,667.88 |
| DRG 312 SYNCOPE AND COLLAPSE | 55 | $24,375.53 | $5,141.67 | $6,636.32 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 54 | $31,945.24 | $5,958.46 | $7,681.44 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 50 | $26,582.62 | $7,416.34 | $8,838.11 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 47 | $34,130.66 | $8,379.79 | $9,867.73 |
| DRG 309 CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | 43 | $21,637.79 | $4,173.47 | $5,247.13 |
| DRG 603 CELLULITIS WITHOUT MCC | 40 | $20,805.93 | $5,001.30 | $6,446.25 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 39 | $54,496.51 | $12,182.28 | $14,289.25 |
| DRG 236 CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MCC | 39 | $77,663.18 | $25,278.85 | $29,653.93 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 36 | $26,893.06 | $6,259.92 | $7,294.77 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 35 | $24,081.34 | $4,787.29 | $5,829.71 |
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5191 Level 1 Endovascular Procedures | 195 | 193 | $1,879.89 | $2,207.96 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 177 | 169 | $1,048.17 | $1,219.56 |
| APC 5302 Level 2 Upper GI Procedures | 151 | 144 | $1,225.64 | $1,444.50 |
| APC 5115 Level 5 Musculoskeletal Procedures | 144 | 136 | $9,079.32 | $10,771.69 |
| APC 8011 Comprehensive Observation Services | 130 | 126 | $1,683.23 | $2,090.36 |
| APC 5213 Level 3 Electrophysiologic Procedures | 106 | 100 | $17,509.84 | $21,117.37 |
| APC 5361 Level 1 Laparoscopy and Related Services | 92 | 90 | $3,688.73 | $4,357.80 |
| APC 5374 Level 4 Urology and Related Services | 84 | 73 | $2,300.91 | $2,629.24 |
| APC 5375 Level 5 Urology and Related Services | 81 | 78 | $3,163.83 | $3,917.51 |
| APC 5183 Level 3 Vascular Procedures | 73 | 70 | $2,046.14 | $2,405.01 |
| APC 5193 Level 3 Endovascular Procedures | 70 | 69 | $7,381.26 | $8,873.86 |
| APC 5182 Level 2 Vascular Procedures | 69 | 64 | $1,020.66 | $1,204.32 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $244K |
| Amgen Inc. | 1 | $122K |
| Genentech, Inc. | 8 | $79K |
| AstraZeneca Pharmaceuticals LP | 1 | $19K |
| Boston Scientific Corporation | 2 | $19K |
| Medtronic, Inc. | 2 | $11K |
| Biotronik Inc. | 57 | $9,222 |
| Abbvie Inc. | 3 | $4,048 |
| Eli Lilly and Company | 3 | $3,611 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $2,500 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.